Literature DB >> 8299575

Age dependence and modulation by gonadectomy of the sex-specific response of rat diaphyseal bone to gonadal steroids.

D Sömjen1, Z Mor, A M Kaye.   

Abstract

We have previously reported that diaphyseal bone of prepubertal rats responds in a sex-specific manner to gonadal steroids, 24 h after steroid injection, by increases in creatine kinase (CK) specific activity and the rate of DNA synthesis. We have also shown that hormonal intervention abolished the sex-specific response of diaphyseal bone to sex steroids. In the present study, we examined the responsiveness of diaphyseal bone and cartilage to gonadal steroids in male and female Wistar-derived rats at ages between 5 days and 1 yr. In both diaphyseal bone and cartilage of untreated control rats, a peripubertal peak of CK specific activity was seen, which was more pronounced in females. Diaphyseal bone, unlike epiphyseal cartilage, responded specifically to a single injection of 17 beta-estradiol (E2; 5 micrograms/rat) in females and to 5 alpha-dihydrotestosterone (DHT; 50 micrograms/rat) in males. The highest response occurred peripubertally, but was skewed toward prepubertal ages in males and postpubertal ages in females. To study the effect of gonadectomy on this sex-specific response of diaphyseal bone, rats were gonadectomized at the age of 24 or 180 days and from 4 days to 4 weeks thereafter were challenged with either E2 or DHT. Diaphyseal bones of gonadectomized rats of either sex responded to both E2 and DHT, beginning 7 days after surgery. Thus, in gonadectomized rats, there was a loss of the sex specificity of response to steroid hormones, which could be restored by replenishment, by five daily injections, of the characteristic hormone of each sex. In the epiphyseal cartilage, the same replenishment schedule resulted in acquisition of a sex-specific response in both sexes, not seen previously. These data in conjunction with the previously reported hormonal modulation of sex-specific responses, are consistent with a developmental acquisition of diaphyseal sex steroid specificity that requires for its maintenance the presence of appropriate amounts of the characteristic gonadal steroid in each sex.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299575     DOI: 10.1210/endo.134.2.8299575

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  DT56a stimulates creatine kinase specific activity in vascular tissues of rats.

Authors:  D Somjen; I Yoles
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

2.  The role of non-calcemic analogs of vitamin D in differentiation of cultured rat bone marrow into osteoblast-like cells: age and sex differences.

Authors:  D Somjen; A M Kaye; M Ofer; I Bleiberg
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

3.  Age and gender specific stimulation of creatine kinase specific activity by gonadal steroids in human bone-derived cells in culture.

Authors:  S Katzburg; A Ornoy; D Hendel; M Lieberherr; A M Kaye; D Somjen
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

4.  Differentiation of cultured mice bone marrow into osteoblast-like cells results in acquisition of sex-specific responsiveness to gonadal steroids.

Authors:  E Berger; I Bleiberg; Y Weisman; A Harel; A M Kaye; D Somjen
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

Review 5.  Unresolved issues in osteoporosis in men.

Authors:  E Seeman
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

6.  Age-dependent responsiveness of human female bone cells to vitamin D analog and PTH.

Authors:  D Somjen; S Katzburg; A M Kaye; G H Posner
Journal:  J Endocrinol Invest       Date:  2013-02       Impact factor: 4.256

7.  Less-calcemic vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in rat skeletal tissues.

Authors:  D Somjen; G H Posner; Y Weisman; A M Kaye
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.